ByJERUSALEM POST STAFF
The 4,700-square-meter facility at Tel Hashomer will include an on-site cyclotron and advanced imaging and targeted-treatment units, the medical center said.
Sheba Medical Center said it will inaugurate a new nuclear medicine facility on Thursday, at its Tel Hashomer campus near Tel Aviv, in a move it described as a major expansion of Israel’s molecular imaging and targeted-therapy capabilities.
The hospital said the site will be named the Roman Abramovich Theranostics and Nuclear Medicine Center, citing philanthropist Roman Abramovich’s support for the project.
The 4,700-square-meter center is designed to diagnose and treat disease at the molecular level using radiopharmaceuticals, Sheba said, with applications spanning cancer, neurological disorders, and cardiovascular disease. The hospital said the center is expected to serve more than 16,000 patients annually.
On-site isotope production and advanced imaging
At the heart of the facility is an on-site cyclotron that will enable Sheba to produce medical isotopes on-site and use them immediately, the hospital said. Sheba said the in-house capability is expected to reduce delays and expand clinical and research options, including participation in trials and international collaborations.
The center will include four dedicated units, Sheba said, a PET/CT zone, a PET/MRI zone, a SPECT/CT zone and a theranostics personalized-medicine unit focused on targeted therapies intended to destroy tumor cells while limiting side effects. “With advanced imaging, on-site isotope production, and targeted therapies, we can detect diseases earlier, tailor treatments precisely, and give hope to patients facing complex conditions,” said Prof. Liran Domachevsky, whom Sheba identified as the center’s head.
Partnerships and Sheba’s wider innovation push
Sheba said the inauguration will bring together hospital leadership, partners, and international collaborators, and framed the project as part of its broader innovation agenda. In recent years, The Jerusalem Post has reported on Sheba’s standing in global hospital rankings and its push into “smart hospital” systems and digital health.
The hospital also highlighted an ongoing collaboration with GE HealthCare focused on AI-driven diagnostics, operational efficiency, and smart hospital infrastructure. “It reflects our shared commitment to advancing future innovations in molecular imaging,” said Yuval Levin, identified as GE HealthCare’s zone sales manager for imaging.
